Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simon S.-P. Fung
Observed names:
S. Fung,
Simon Fung
Institution:
Springer Nature (New Zealand)
Observed institutions:
European Organisation for Research and Treatment of Cancer,
University of Leicester,
University of Auckland,
Springer Nature (New Zealand)
ORCID:
0000-0003-0789-7765
Observed ORCID:
0000-0003-0789-7765
OpenAlex ID:
A5025018257
Unravelling the mechanisms controlling heme supply and demand
2021
·
Galvin C.-H. Leung
, Simon S.-P. Fung
, et al.
·
Proceedings of the National Academy of Sciences
·
37
Durvalumab: A Review in Advanced Biliary Tract Cancer
2023
·
Simon Fung
, Yahiya Y. Syed
·
Targeted Oncology
·
26
PDF
Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
2023
·
Simon Fung
, Matt Shirley
·
CNS Drugs
·
25
Correction to: Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema
2022
·
Simon Fung
, Yahiya Y. Syed
·
Drugs
·
24
PDF
Baricitinib: A Review in Severe Alopecia Areata
2023
·
Simon Fung
, Matt Shirley
·
American Journal of Clinical Dermatology
·
19
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema
2022
·
Simon Fung
, Yahiya Y. Syed
·
Drugs
·
16
PDF
Garadacimab: First Approval
2025
·
Simon Fung
·
Drugs
·
15
Rezafungin: A Review in Invasive Candidiasis
2025
·
Simon Fung
, Matt Shirley
·
Drugs
·
14
Abemaciclib: A Review in Early Breast Cancer with a High Risk of Recurrence
2023
·
Simon Fung
, Hannah A. Blair
·
Targeted Oncology
·
13
Ifupinostat: First Approval
2025
·
Simon Fung
·
Drugs
·
12
Precise determination of heme binding affinity in proteins
2019
·
Galvin C.-H. Leung
, Simon S.-P. Fung
, et al.
·
Analytical Biochemistry
·
11
Vonoprazan: A Review in Erosive Esophagitis and Non-Erosive Gastro-Esophageal Reflux Disease
2025
·
Simon Fung
·
Drugs
·
10
Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy
2022
·
Simon Fung
, Matt Shirley
·
Drugs
·
9
Nipocalimab: First Approval
2025
·
Simon Fung
·
Drugs
·
8
Sovateltide in cerebral ischaemic stroke: a profile of its use
2024
·
Simon Fung
, Yahiya Y. Syed
·
Drugs & Therapy Perspectives
·
3
Management of central neuropathic pain involves many drugs but few have proven efficacy
2022
·
Simon Fung
, Connie Kang
·
Drugs & Therapy Perspectives
·
3
Fosrolapitant/Palonosetron: First Approval
2025
·
Simon Fung
·
Drugs
·
2
Oteseconazole in recurrent vulvovaginal candidiasis: a profile of its use
2023
·
Simon Fung
, Matt Shirley
·
Drugs & Therapy Perspectives
·
2
Deuruxolitinib: New Approval
2026
·
Simon Fung
·
Clinical Drug Investigation
·
1
Reduce tonic-clonic seizures with antiseizure medications to lower the risk of sudden unexpected death in epilepsy
2026
·
Kimberley Chen
, Simon Fung
·
Drugs & Therapy Perspectives
·
1
PDF
Consider the cardiovascular and pulmonary effects of treatments in patients with both asthma and cardiovascular disease
2025
·
Simon Fung
·
Drugs & Therapy Perspectives
·
1
Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use
2024
·
Simon Fung
, Hannah A. Blair
·
Drugs & Therapy Perspectives
·
1
Eradicate Helicobacter pylori in older patients with quad or triple therapy
2024
·
Caroline Fenton
, Simon Fung
·
Drugs & Therapy Perspectives
·
1
Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study
2024
·
Simon Fung
·
Drugs & Therapy Perspectives
·
1
Efanesoctocog alfa in hemophilia A: a profile of its use
2024
·
Simon Fung
, Hannah A. Blair
·
Drugs & Therapy Perspectives
·
1
PDF
Show more works
View as search
Works count:
61
Citation count:
257
H-index:
11
I10-index:
12
Year
Topic
Type
